References
- Messing R B, Lytle L D. Serotonin-containing neurons: their possible role in pain and analgesia. Pain 1977; 4: 1–21
- Basbaum A I, Fields H L. Endogenous pain control mechanisms: review and hypothesis. Ann Neurol 1978; 4: 451–62
- Sicuteri F, Anselmi B, Del Bianco P L. 5-hydroxytryptamine supersensitivity as a new theory of headache and central pain: a clinical pharmacological approach with p-chlorophenylalanine. Psychopharmacologia 1973; 29: 347–56
- Almay B G L, Uggendal J, von Knorring L, Oreland L. 5-HIAA and HVA in CSF in patients with idiopathic pain disorders. Biol Psychiatry 1987; 22: 403–12
- Millinger G S. Neutral amino acid therapy for the management of chronic pain. Cranio 1986; 4: 157–63
- Johansson F, von Knorring L. A double blind controlled study of a serotonin uptake inhibitor (zimelidine) versus placebo in chronic pain patients. Pain 1979; 7: 69–78
- Eberhard G, von Knorring L, Nilsson H L, et al. A double-blind randomized study of clomipramine versus maprotiline in patients with idiopathic pain syndromes. Neuropsychobiology 1988; 19: 25–34
- Messing R B, Phebus L, Fisher L. Analgesic effect of fluoxetine hydrochloride (Lilly 119140) a specific inhibitor of serotonin uptake. Psychopharmacol Commun 1975; 1: 511–21
- Ottevanger E A. Fluvoxamine – highly selective 5-HT-reuptake inhibitor. Basic broschure. Duphar, Holland 1987
- Rowland N E, Carlton J. Neurobiology of an anorectic drug: fenfluramine. Prog Neurobiol 1986; 27: 13–62
- Murphy D L, Mueller E A, Garrick N A, Aulakh C S. Use of serotonergic agents in the clinical assessment of central serotonin function. J Clin Psychiatry 1986; 47: 9–15
- van Praag H M, Lemus C, Kahn R. Hormonal probes of central serotonergic activity: do they really exist?. Biol Psychiatry 1987; 22: 86–98
- Mühlbauer H D, Müller-Oerlinghausen B. Fenfluramine stimulation of serum Cortisol in patients with major affective disorders and healthy controls: further evidence for a central serotonergic action in man. J Neural Transm 1985; 61: 81–94
- Asnis G M, Eisenberg J, van Praag H M, Lemus C Z, Friedman J M, Miller A H. The neuroendocrine response to fenfluramine in depressive and normal controls. Biol Psychiatry 1988; 24: 117–20
- Sternbach R A. Pain patients. Traits and treatment. Academic Press, London 1974
- von Knorring L. The experience of pain in patients with depressive disorders. A clinical and experimental study. Umeå University Medical DissertationsNew series. No. 2. Umeå university, Umeå 1975
- Almay B G L. Patients with idiopathic pain syndromes. A clinical, biochemical and neuroendocrinological study. Umeå University Medical DissertationsNew series. No. 191. Umeå university. 1987
- von Knorring L. Affect and pain: neurochemical mediators and therapeutic approaches. Proceedings of the Vth World Congress on Pain., R Dubner, G F Gebhart, M R Bond. Elsevier Science Publishers BV.Ch., North Holland 1988; 30: 276–85
- von Knorring L, Almay B G L, Ekman R, Widerlöv E. Biological markers in chronic pain syndromes. Nord J Psychiatry 1988; 42: 139–46
- Siever L J, Murphy D L, Slater S, de la Vega E, Upper S. Plasma prolactin changes following fenfluramine in depressed patiented compared to controls: an evaluation of central serotonergic responsitivity in depression. Life Sci 1984; 34: 1029–39
- Ward N G, Bokan J A, Ang J, Butler S H. Differential effects of fenfluramine and dextroamphetamine on acute and chronic pain. Advances in Pain Research and Therapy, H L Fields, et al. Raven Press, New York 1985; 9, 753–60
- Williams J B, Spitzer R L. Idiopathic pain disorder: a critique of prain-prone disorder and a proposal for a revision of the DSM-III category psychogenic pain disorder. J Nerv Ment Dis 1982; 170: 415–9
- Johansson F, von Knorring L. Changes in serum prolactin after electroconvulsive and epileptic seizures. Eur Arch Psychiatry Neurol Sci 1987; 236: 312–8
- Johansson F. Patienets with chronic pain. A clinical, clinicalpharmacological and biochemical study. Umeå University Medical Dissertations. Umeå University, Umeå 1982, New series. No. 87